EMEA-001135-PIP01-11
Key facts
| Invented name |
Forsteo
|
| Active substance |
teriparatide
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/189/2011
|
| PIP number |
EMEA-001135-PIP01-11
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|